Target Name: ZNF398
NCBI ID: G57541
Review Report on ZNF398 Target / Biomarker Content of Review Report on ZNF398 Target / Biomarker
ZNF398
Other Name(s): zinc finger protein 398 | Zinc finger-estrogen receptor interaction, clone 6 | zinc finger DNA binding protein ZER6 | zinc finger DNA binding protein p52/p71 | zinc finger-estrogen receptor interaction, clone 6 | ZER6 | P71 | Zinc finger DNA-binding protein p52/p71 | P51 | ZNF398 variant 1 | Zinc finger protein 398 (isoform a) | ZN398_HUMAN | Zinc finger DNA binding protein p52/p71 | KIAA1339 | p71-ZER6 | Zinc finger protein 398 | Zinc finger DNA binding protein ZER6 | Zinc finger protein 398, transcript variant 1

ZNF398: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF398, a member of the ZNF family, is a protein that has been identified as a potential drug target and biomarker. In this article, we will discuss the ZNF398 protein, its function, potential drug targets, and its potential as a biomarker for various diseases.

Function and localization

ZNF398 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and gastrointestinal tract. It is primarily localized to the cytoplasm and has been shown to be involved in various cellular processes, including cell signaling, DNA replication, and repair, cell adhesion, and inflammation.

Potential drug targets

ZNF398 is a protein that has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. One of the most promising potential drug targets for ZNF398 is its role in cancer. ZNF398 has been shown to be involved in the regulation of cell proliferation and has been shown to play a role in the development of various types of cancer.

In addition to its role in cancer, ZNF398 has also been shown to be involved in the regulation of neurodegenerative diseases. Alzheimer's disease is a neurodegenerative disease that is characterized by the progressive loss of brain cells, and ZNF398 has been shown to be involved in the regulation of the immune response and the development of neurodegenerative diseases.

Potential biomarkers

ZNF398 has also been shown to be potential biomarker for various diseases. One of the most promising applications of ZNF398 as a biomarker is its ability to be used as a diagnostic marker for cancer. ZNF398 has been shown to be expressed in various types of cancer, including breast, lung, and ovarian cancer. This makes it a promising biomarker for cancer diagnosis and screening.

In addition to its potential as a diagnostic marker, ZNF398 has also been shown to be a potential biomarker for neurodegenerative diseases. The progressive loss of brain cells in neurodegenerative diseases is a hallmark of the disease, and ZNF398 has been shown to be involved in the regulation of the immune response and the development of neurodegenerative diseases. This makes it a promising biomarker for neurodegenerative diseases.

Conclusion

ZNF398 is a protein that has been shown to play a role in various cellular processes and has been identified as a potential drug target and biomarker. Its function as a protein involved in cell signaling, DNA replication, and repair, cell adhesion, and inflammation makes it a promising candidate for drug development. Its potential as a diagnostic marker for cancer and a biomarker for neurodegenerative diseases makes it a promising tool for the development of new treatments for these diseases.

Protein Name: Zinc Finger Protein 398

Functions: Functions as a transcriptional activator

The "ZNF398 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF398 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534